D-Pharma SRL
The score of D-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +570 % Total assets +429 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
D-Pharma's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 29 Jan 2026
- Year ended 30 Sep 2024filed on 28 Apr 2025
- Year ended 30 Sep 2023filed on 29 Apr 2024
D-Pharma's financial analysis
- Solvency86.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of D-Pharma
D-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0804.682.997
- VAT number
- BE0804682997
- Peppol
- Registered · 0208:0804682997 · as of 03 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Aug 2023
- Registered office
- 2930 Brasschaat
- Latest accounts
- 2025 · filed on 29 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
D-Pharma (SRL) has been based in Brasschaat since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 80,212 € and equity of 195,050 €; its revenue is not published. Its solvency stands at 86.1%, above the median of its sector (44.2%).
Companies similar to D-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- White-TO-Black Retail sale of pharmaceutical products Dilbeek · balance sheet 209,334 €
- Farmafender Retail sale of pharmaceutical products Zedelgem · balance sheet 269,880 €
- Liwoma Retail sale of pharmaceutical products Kontich · balance sheet 289,010 €
- Sarina Janssens Farma Retail sale of pharmaceutical products Bierbeek · balance sheet 136,654 €
- AVA-Rose Retail sale of pharmaceutical products Jette · balance sheet 381,859 €
- Karbon Plus Retail sale of pharmaceutical products Diksmuide · balance sheet 127,790 €
- Apocurae Retail sale of pharmaceutical products Kortemark · balance sheet 124,948 €
Frequently asked questions about D-Pharma
What is the revenue of D-Pharma?
D-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of D-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0804682997 for D-Pharma, if the company is VAT-registered. Its company number (CBE) is 0804.682.997.
Where is the registered office of D-Pharma?
According to the CBE register, the registered office of D-Pharma is in 2930 Brasschaat.
What is the equity of D-Pharma?
At the close of the 2025 financial year, the equity of D-Pharma amounts to 195,050 €, a solvency of 86.1% of total assets.
Who manages D-Pharma?
The register lists 1 active mandates at D-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of D-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →